Ignite Creation Date:
2024-05-06 @ 6:57 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05840510
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-21
First Post:
2023-04-12
Brief Title:
Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation KRYSTAL -19
Sponsor:
Mirati Therapeutics Inc
Organization:
Mirati Therapeutics Inc
Organization Data
Organization:
Mirati Therapeutics Inc
Class:
INDUSTRY
Study ID:
CA239-0011
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mirati Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Aadi Bioscience Inc | INDUSTRY |